Regulatory Considerations for Cancer Immunotherapies:​ Preclinical Focus​

The "Regulatory Considerations for Cancer Immunotherapies:​ Preclinical Focus​" course is one of 18 course in the Introduction to Immuno- Safety Science.  

This course is led by Dr. Mary Ellen Cosenza, Ph.D. DABT, ERT, RAC, ATS​ - at Toxicology consulting.

Learning Objectives

  • Types of Immunotherapies and what makes them different ​

  • The Regulatory Process for development of novel therapeutics​

  • Regulatory Considerations for Preclinical Development of advanced oncology drugs and biologics   ​

  • Entering Clinical Trials ​

  • Later Stage Development 

Course summary
Course opens: 
03/22/2022
Course expires: 
03/30/2027
Cost:
$25.00
Part of: 
Cancer Immunotherapies
Rating: 
0

Price

Cost:
$25.00
Please login or register to take this course.